Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.
about
Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.Challenges of antibacterial discoveryImpact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.Prevalence and Susceptibility Pattern of Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa in KarachiResistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010.Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast OhioClinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomesExploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.Impact of a Multimodal Antimicrobial Stewardship Program on Pseudomonas aeruginosa Susceptibility and Antimicrobial Use in the Intensive Care Unit Setting.Pseudomonas aeruginosa: resistance to the maxDetection of Metallo-Beta Lactamases Among Carbapenem-Resistant Pseudomonas aeruginosa.In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms.Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia.Outcomes of appropriate empiric combination versus monotherapy for Pseudomonas aeruginosa bacteremia.Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009)Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model.Prevalence of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant Pseudomonas aeruginosa from a Tertiary Level Intensive Care Unit.In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.Pseudomonas aeruginosa treatment and transmission reduction.Cu-mediated enamide formation in the total synthesis of complex peptide natural products.Carbapenem susceptibility breakpoints, clinical implications with the moving target.Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature.Quorum-Sensing Mechanisms and Bacterial Response to Antibiotics in P. aeruginosa.Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections.Phenotypic and molecular characterization of antimicrobial resistance and virulence factors in Pseudomonas aeruginosa clinical isolates from Recife, State of Pernambuco, Brazil.Expansion of Antibacterial Spectrum of Muraymycins toward Pseudomonas aeruginosa.Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art.Disk Carbapenemase Test for the Rapid Detection of KPC-, NDM-, and Other Metallo-β-Lactamase-Producing Gram-Negative Bacilli.Detection of Carbapenemases in Clinical Enterobacteriaceae Isolates Using the VITEK AST-N202 Card.Application of the multifactor dimensionality reduction method in evaluation of the roles of multiple genes/enzymes in multidrug-resistant acquisition in Pseudomonas aeruginosa strains.Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in KoreaActivation of the lectin pathway of complement in experimental human keratitis with Pseudomonas aeruginosa.In vitro potency of various polymyxin B components.Up-regulating pyocyanin production by amino acid addition for early electrochemical identification of Pseudomonas aeruginosa.Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.Progress and challenges in implementing the research on ESKAPE pathogens.Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases.In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa.
P2860
Q30430870-D8D94B6A-F752-4D1F-921D-B1C45EDFB53BQ30530476-A0E4B796-8E45-4C23-9838-976B3840EAF0Q33793074-9E065D72-4EBA-45E9-BD48-D0B16E0C8EDAQ34108708-F700EB7F-FDCF-4BD6-9407-9613C0FB882AQ34176098-1250D062-4B97-45C3-950B-9C34C36F5F64Q34296375-C1514B8C-98DE-4E0E-98CE-727F33B615B3Q34298956-3B57A8FA-F222-4D3A-BABB-DA000B1DD390Q34446914-741014B6-3F77-46DC-8A10-31E8179FC060Q34766191-2249D8EE-FCFC-4AF6-B7CD-8E858BC6894CQ35014136-85F6819C-9389-406F-9B15-CC2B3CD019E3Q35040023-D6766526-B757-469C-96FA-A190EB2C2636Q35084559-12D87B01-4BF1-41A5-8F77-B6A438AC61DFQ35094250-9DFC97CE-C2F9-41FB-9298-32379F517EC5Q35666617-029287DE-97F2-4760-9F84-4872254B76CBQ36471098-C660F125-0846-4782-9CBE-D0EAB2C3D63BQ36667202-1A8552CD-1157-4B34-B78A-CA08D6FF66C7Q37162468-E7116300-AE97-4D0B-A638-49FE695EDEFEQ37360650-681D28E6-8733-4EA9-9869-4DFB8099307DQ37449612-23296052-8338-43D3-841A-21EBD3E27ECDQ37712983-1E9AF417-08EE-4306-9150-C8EA500A5BD4Q38131538-640B2502-176E-4774-8674-F9E26126CFF6Q38190893-E952A656-6EDA-4838-814B-BEEB90EC8D16Q38751264-AAE53CE2-F6FB-4DBF-BE65-4DAC414D7036Q38809322-706495FE-8C56-4A37-BB78-3E90E6566431Q38905910-2E1AF133-A2D2-4B5A-959E-8922D32E13FEQ39037981-7D46DD74-560B-4320-B2C1-E2E0F1BFA422Q39113907-FFD97DDC-98DE-495A-8F08-88A027A56339Q39781380-FEE6CF5C-9784-4A34-9B83-10E81BFE1F84Q40095692-39610471-45A7-4EE0-ADB6-E52C2D55944AQ40626802-C5149559-9791-4298-BD68-3FC680DA27D1Q40944630-DE262FFD-B9DF-4C22-8BE9-202429C304A0Q41076559-EE9A9CD0-6B50-45C7-BF66-221EBC4620E4Q41785493-10C22EDB-D153-4855-83F3-46F3AE830273Q41865741-1663BBE7-FFEB-4D3A-A524-2F2519927F09Q42881737-095CFFF9-675F-4E04-9678-5A4AE957F8D5Q45300100-F4EB5F2F-98DB-4E8A-8B84-A1685E891EBCQ45365673-0BD6AFAF-0D65-4353-9FAD-CE1998A720CDQ45710828-B655F235-093D-4B63-8F46-51C28FACA251Q47102895-F8419C49-B70A-4C27-9632-4C9097ADB074Q50792742-3820E7A6-3216-46E9-BDE1-F1CBC7BB4871
P2860
Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Prevalence, resistance mechani ...... tes of Pseudomonas aeruginosa.
@en
Prevalence, resistance mechani ...... tes of Pseudomonas aeruginosa.
@nl
type
label
Prevalence, resistance mechani ...... tes of Pseudomonas aeruginosa.
@en
Prevalence, resistance mechani ...... tes of Pseudomonas aeruginosa.
@nl
prefLabel
Prevalence, resistance mechani ...... tes of Pseudomonas aeruginosa.
@en
Prevalence, resistance mechani ...... tes of Pseudomonas aeruginosa.
@nl
P2093
P2860
P356
P1476
Prevalence, resistance mechani ...... tes of Pseudomonas aeruginosa.
@en
P2093
Cristina G Brioso
Jaye S Weston
Juan-Pablo Caeiro
Kai-Tai Chang
Kamilia Abdelraouf
Laurie A McCaskey
Magdalene Ameka
Vincent H Tam
P2860
P304
P356
10.1128/AAC.01446-09
P407
P577
2010-01-19T00:00:00Z